These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 15657824)
1. [Potential advantages of the MRI for the radiofrequency ablation of liver tumors]. Gaffke G; Gebauer B; Gnauck M; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C Rofo; 2005 Jan; 177(1):77-83. PubMed ID: 15657824 [TBL] [Abstract][Full Text] [Related]
2. Use of semiflexible applicators for radiofrequency ablation of liver tumors. Gaffke G; Gebauer B; Knollmann FD; Helmberger T; Ricke J; Oettle H; Felix R; Stroszczynski C Cardiovasc Intervent Radiol; 2006; 29(2):270-5. PubMed ID: 16328685 [TBL] [Abstract][Full Text] [Related]
3. [Percutaneous radiofrequency ablation of liver tumors using the LeVeen 4 cm array probe]. Pitton MB; Herber S; Raab P; Mönch C; Wunsch M; Schneider J; Schweden F; Otto G; Thelen M Rofo; 2003 Nov; 175(11):1525-31. PubMed ID: 14610704 [TBL] [Abstract][Full Text] [Related]
4. Image-guided radiofrequency ablation of hepatocellular carcinoma (HCC): is MR guidance more effective than CT guidance? Clasen S; Rempp H; Hoffmann R; Graf H; Pereira PL; Claussen CD Eur J Radiol; 2014 Jan; 83(1):111-6. PubMed ID: 24161781 [TBL] [Abstract][Full Text] [Related]
5. [Flexible applicator systems for radiofrequency ablation (RFA) of hepatic tumors]. Gebauer B; Gaffke G; Hünerbein M; Felix R; Stroszczynski C Rofo; 2003 Dec; 175(12):1720-3. PubMed ID: 14661145 [TBL] [Abstract][Full Text] [Related]
6. Percutaneous radiofrequency ablation of renal tumors: midterm results in 16 patients. Memarsadeghi M; Schmook T; Remzi M; Weber M; Pötscher G; Lammer J; Kettenbach J Eur J Radiol; 2006 Aug; 59(2):183-9. PubMed ID: 16725292 [TBL] [Abstract][Full Text] [Related]
7. Multipolar hepatic radiofrequency ablation using up to six applicators: preliminary results. Bruners P; Schmitz-Rode T; Günther RW; Mahnken A Rofo; 2008 Mar; 180(3):216-22. PubMed ID: 18278730 [TBL] [Abstract][Full Text] [Related]
8. Bipolar radiofrequency ablation of liver metastases during laparotomy. First clinical experiences with a new multipolar ablation concept. Ritz JP; Lehmann KS; Reissfelder C; Albrecht T; Frericks B; Zurbuchen U; Buhr HJ Int J Colorectal Dis; 2006 Jan; 21(1):25-32. PubMed ID: 15875202 [TBL] [Abstract][Full Text] [Related]
9. [Radiofrequency ablation of renal cell carcinomas using MR imaging: initial results]. Boss A; Clasen S; Kuczyk M; Anastasiadis A; Schmidt D; Claussen CD; Schick F; Pereira PL Rofo; 2005 Aug; 177(8):1139-45. PubMed ID: 16021547 [TBL] [Abstract][Full Text] [Related]
10. MR-guided radiofrequency ablation in a 0.2-T open MR system: technical success and technique effectiveness in 100 liver tumors. Clasen S; Boss A; Schmidt D; Schraml C; Fritz J; Schick F; Claussen CD; Pereira PL J Magn Reson Imaging; 2007 Oct; 26(4):1043-52. PubMed ID: 17896364 [TBL] [Abstract][Full Text] [Related]
11. FDG positron emission tomography in the surveillance of hepatic tumors treated with radiofrequency ablation. Anderson GS; Brinkmann F; Soulen MC; Alavi A; Zhuang H Clin Nucl Med; 2003 Mar; 28(3):192-7. PubMed ID: 12592125 [TBL] [Abstract][Full Text] [Related]
12. Magnetic resonance-guided freehand radiofrequency ablation of malignant liver lesions: a new simplified and time-efficient approach using an interactive open magnetic resonance scan platform and hepatocyte-specific contrast agent. Fischbach F; Lohfink K; Gaffke G; Wybranski C; Mohnike K; Wonneberger U; Pech M; Jungnickel K; Ricke J; Strach K Invest Radiol; 2013 Jun; 48(6):422-8. PubMed ID: 23399808 [TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338 [TBL] [Abstract][Full Text] [Related]
15. Role of B-mode ultrasound screening in detection of local tumor recurrence in the first year after radiofrequency ablation in the liver. Eisele RM; Schumacher G; Lopez-Hänninen E; Neuhaus P Cancer Detect Prev; 2007; 31(4):316-22. PubMed ID: 17935909 [TBL] [Abstract][Full Text] [Related]
16. [Percutaneous radiofrequency ablation of liver malignancies: first experience with a 200-W radiofrequency generator]. Mahnken AH; Tacke J; Bücker A; Günther RW Rofo; 2002 Feb; 174(2):216-23. PubMed ID: 11898085 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of different magnetic resonance imaging sequences for detecting local tumor progression after radiofrequency ablation of hepatic malignancies. Weiss J; Rempp H; Clasen S; Notohamiprodjo M; Keßler DE; Pereira PL; Blumenstock G; Nikolaou K; Hoffmann R Eur J Radiol; 2017 Sep; 94():85-92. PubMed ID: 28655432 [TBL] [Abstract][Full Text] [Related]
18. Intrahepatic tumor recurrence after partial hepatectomy: value of percutaneous radiofrequency ablation. Schindera ST; Nelson RC; DeLong DM; Clary B J Vasc Interv Radiol; 2006 Oct; 17(10):1631-7. PubMed ID: 17057005 [TBL] [Abstract][Full Text] [Related]
19. In vitro artefact assessment of a new MR-compatible microwave antenna and a standard MR-compatible radiofrequency ablation electrode for tumour ablation. Hoffmann R; Rempp H; Eibofner F; Keßler DE; Blumenstock G; Weiß J; Pereira PL; Nikolaou K; Clasen S Eur Radiol; 2016 Mar; 26(3):771-9. PubMed ID: 26134999 [TBL] [Abstract][Full Text] [Related]
20. Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome. Zytoon AA; Ishii H; Murakami K; El-Kholy MR; Furuse J; El-Dorry A; El-Malah A Jpn J Clin Oncol; 2007 Sep; 37(9):658-72. PubMed ID: 17766723 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]